Trial Information

Summary: An International, Double-Blind, Parallel-Group, Placebo-Controlled, Randomized Study: Evaluation of the Efficacy and Safety of Brivaracetam in Subjects (> 16 to 70 years old) with Partial Onset Seizures.

The main purpose of this study is to find out how safe and effective different doses of brivaracetam are in reducing the frequency of seizures in patients who have partial onset seizures.

Qualified participants must be:

  • between 16 and 70 years of age
  • experiencing partial onset seizures and are regularly taking one or two other antiepileptic drugs.


Contact:

Marjorie Baldwin, BSN, RN or Lynda Seal, BSN, RN, Senior Research Nurses
University of Arizona, Health Science Center, Department of Neurology
1501 N. Campbell Avenue, Room 7329
Tucson, AZ 85724-5023
Telephone: 520-626-4296 or 520-626-0868
Fax: 520-626-4903
Email:

Profile Page: University of Arizona, Health Science Center, Department of Neurology, Tucson, AZ

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:37:19 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA